The ultra-low temperature freezers industry is anticipated to grow during the forecast period due to increased investments in pharmaceutical development. When preserving samples at particular temperatures, ultra-low temperature freezers are crucial. Improvements in drug research and clinical testing and the rise in cancer cases and other infectious disorders drive the market. Access to ultra-low temperature freezers has considerably enhanced the capacity for vaccine storage. The ability to transmit vaccinations worldwide in an ultra-cold chain is also growing.
In the life sciences sector, biomolecules are kept in ultra-low temperature (ULT) freezers, sometimes known as -80 freezers, for extended periods. To avoid the denaturation of biomolecules like oligonucleotides and proteins due to heat, they usually provide a temperature range of -40°C to -86°C or -40°F to -123°F. ULT freezers include two doors, with the inner door restricting the passage of unwanted heat to keep the freezer's interior at a consistent temperature. The door's edges are sealed with a silicone gasket and external knob to ensure a tight seal. The polyurethane walls of ULT freezers also provide strong heat insulation from the outside environment.
As of today, the growth of the ultra-low temperature freezers industry is majorly driven by the
biomedical industry. The ultra-low temperature freezers market has grown quickly since the pandemic began, which is encouraging for the biomedical sector. Because of this, many businesses in this sector have made significant investments in R&D. As a result, ultra-low temperature freezers, which are far better at keeping biological material that is extremely sensitive to even little changes in temperature, have been developed and marketed. Businesses have been investing in these new technologies, particularly in Asia-Pacific.
The ultra-low temperature freezers market is anticipated to grow at a 4.20% CAGR from 2022 to 2030, reaching USD 598.36 million.
On the other hand, increased demand for donor organs and raised awareness of organ donation have been rapidly ruling the ultra-low temperature freezers industry. The demand for organ donation has increased due to increased incidences of organ failure in people with chronic conditions. The national transplant waiting list now has 105,924 men, women, and children on it, and 17 individuals pass away per day while they are on the list. This information comes from the Health Resources and Services Administration. About 122,913 individuals in the US were awaiting organ transplants in 2019, according to the US Department of Health and Human Services.
A true world-destiny changer, the COVID-19 pandemic is to the 21st century what the Black Death was to the 5th and 14th centuries AD. Most people wanted to avoid COVID-19 like the plague because it was such a terrible virus (no pun intended!). Governments worldwide implemented lockdowns and quarantines as a result of realizing this. Since they weren't particularly effective, these were meant to be transitory. As a result of being compelled to temporarily suspend operations or shut down for an unforeseen amount of time, numerous businesses across numerous industries suffered unfavorable effects.
Significant changes in the market for ultra-low temperature freezers worldwide
- Haier Biomedical introduced the DW-86L828ST new-generation ULT freezer in June 2022. TwinCool technology, Frequency Conversion technology, and Hydrocarbon energy-saving technology are all integrated into this freezer.
Thermo Fisher Scientific introduced its cutting-edge TSX Series ULT Freezers in June 2021. These systems are the only ones to feature an outside illumination option, which makes use simpler by allowing immediate visual evaluation of the freezer's condition.
